Brock Medical, LLC

Brock Medical, LLC was paid $63.70M by Medicaid between Jan 2018 and Dec 2024, across 54 billing codes. Its largest line is S9083, Global fee urgent care centers — 54% of everything it billed.

33Billing provider infoBROCK MEDICAL, LLC
LONDON, KY 40741

33aNPI1023379815assigned 06/07/2012

33bProvider typeNurse Practitioner

28Total paid$63.70M

24GClaims1,656,561

24DCodes billed54

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Nurse Practitioner providers in Kentucky

Rank by total paid#1 of 260

Median peer was paid$89K

This provider vs. median715×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	184,342	$7.05M
2019	220,208	$8.58M
2020	231,084	$9.33M
2021	272,145	$11.79M
2022	269,509	$11.08M
2023	289,635	$9.53M
2024incomplete	189,638	$6.34M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
S9083	Global fee urgent care centers	54%	333,029	299,717	$34.46M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	14%	186,893	169,505	$8.68M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	11%	168,379	154,111	$6.86M
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	7.5%	244,872	222,087	$4.78M
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	5.1%	62,474	56,116	$3.23M
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	2.3%	266,052	129,337	$1.46M
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	2.0%	18,509	16,935	$1.26M
87428		1.9%	34,558	31,786	$1.23M
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	1.3%	165,992	152,424	$848K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	41,848	37,880	$275K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	6,960	5,668	$257K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	9,254	6,891	$108K

42 more codes

99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	2,384	$76K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	4,527	$54K
96127		<1%	19,190	$39K
87807		<1%	5,574	$23K
71046	Radiologic examination, chest; 2 views	<1%	2,452	$17K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	22,120	$9K
81003		<1%	26,633	$8K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	277	$3K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	772	$3K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	3,231	$2K
99406		<1%	540	$2K
99215	Doctor's office visit, returning patient (complex)	<1%	15	$1K
99205	Prolong outpt/office vis	<1%	14	$1K
90756		<1%	100	$1K
90674		<1%	113	$1K
99051		<1%	4,833	$1K
74018		<1%	83	$742.03
86308		<1%	172	$449.24
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	53	$372.26
82962		<1%	217	$226.41
81025		<1%	210	$190.29
73610		<1%	12	$168.86
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	77	$156.48
36415	Collection of venous blood by venipuncture	<1%	63	$143.34
73630		<1%	36	$135.59
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	25	$67.72
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	328	$10.73
A6448	Light compression bandage, elastic, knitted/woven, width less than three inches, per yard	<1%	41	$8.29
99000		<1%	970	$7.43
J7510	Prednisolone oral, per 5 mg	<1%	13	$4.95
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	42	$2.79
J8540	Dexamethasone, oral, 0.25 mg	<1%	19	$2.75
3725F		0%	9,201	$0.00
888888		0%	5,414	$0.00
4004F		0%	178	$0.00
3351F		0%	6,751	$0.00
3352F		0%	451	$0.00
3353F		0%	280	$0.00
4000F		0%	178	$0.00
96373		0%	82	$0.00
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	0%	13	$0.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	57	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDEANE, ANDREW (VP FINANCE)

Same official

Other billing entities under DEANE, ANDREW

Full network →

Provider	Location	Paid
FC Indiana, LLC	Bedford, IN	$7.22M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.